Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iBio (IBIO) Equity Ratio (2016 - 2025)

iBio (IBIO) has disclosed Equity Ratio for 15 consecutive years, with 0.88 as the latest value for Q4 2025.

  • On a quarterly basis, Equity Ratio rose 37.16% to 0.88 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.88, a 37.16% increase, with the full-year FY2025 number at 0.64, down 13.52% from a year prior.
  • Equity Ratio was 0.88 for Q4 2025 at iBio, up from 0.87 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.88 in Q4 2025 to a low of 0.27 in Q4 2023.
  • A 5-year average of 0.61 and a median of 0.64 in 2024 define the central range for Equity Ratio.
  • Peak YoY movement for Equity Ratio: surged 683.83% in 2021, then plummeted 49.28% in 2022.
  • iBio's Equity Ratio stood at 0.72 in 2021, then tumbled by 49.28% to 0.36 in 2022, then decreased by 25.61% to 0.27 in 2023, then skyrocketed by 136.9% to 0.64 in 2024, then surged by 37.16% to 0.88 in 2025.
  • Per Business Quant, the three most recent readings for IBIO's Equity Ratio are 0.88 (Q4 2025), 0.87 (Q3 2025), and 0.64 (Q2 2025).